A case of chronic myelogenous leukemia with e8a2 fusion transcript

Area of Science:

• Hematology
• Molecular Biology
• Oncology

Background:

• The Philadelphia chromosome and BCR-ABL fusion gene are key genetic markers in hematological malignancies.
• BCR-ABL rearrangements are common in chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL).
• Standard BCR-ABL transcripts include major (e1a2) and minor (e19a2) variants.

Observation:

• An unusual band was detected during RT-PCR analysis for BCR-ABL gene rearrangement in a CML patient.
• This unexpected band indicated a non-standard BCR-ABL transcript variant.

Findings:

• Sequence analysis confirmed a rare e8a2 BCR-ABL fusion.
• The fusion transcript contained a 14-bp insertion from ABL intron Ia.
• The patient achieved complete hematological response to imatinib therapy within 3 months.

Implications:

• This case highlights the existence of rare BCR-ABL variants, such as e8a2.
• Unexpected findings in RT-PCR may signify novel or uncommon gene fusions.
• Awareness of unusual variants is crucial for accurate diagnosis and effective treatment of CML.